Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Expensify (EXFY) over the last 6 years, with Q3 2025 value amounting to $462000.0.

  • Expensify's Gains from Investment Securities fell 6435.19% to $462000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 6645.25%. This contributed to the annual value of $5.1 million for FY2024, which is 2077.48% down from last year.
  • Latest data reveals that Expensify reported Gains from Investment Securities of $462000.0 as of Q3 2025, which was down 6435.19% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Expensify's Gains from Investment Securities ranged from a high of $5.7 million in Q2 2023 and a low of $12000.0 during Q4 2021
  • Its 5-year average for Gains from Investment Securities is $1.6 million, with a median of $1.2 million in 2022.
  • The largest annual percentage gain for Expensify's Gains from Investment Securities in the last 5 years was 960000.0% (2022), contrasted with its biggest fall of 9345.54% (2022).
  • Over the past 5 years, Expensify's Gains from Investment Securities (Quarter) stood at $12000.0 in 2021, then soared by 9600.0% to $1.2 million in 2022, then soared by 392.78% to $5.7 million in 2023, then tumbled by 76.69% to $1.3 million in 2024, then tumbled by 65.45% to $462000.0 in 2025.
  • Its Gains from Investment Securities stands at $462000.0 for Q3 2025, versus $3.8 million for Q2 2025 and $585000.0 for Q1 2025.